American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 29, Issue 1 , Pages 24-30 , January 2008

Combination antifungal therapy for invasive aspergillosis: can it replace high-risk surgery at the skull base?

  • Naresh K. Panda, MS,DNB,FRCS (Ed)

      Affiliations

    • Department of Otolaryngology and Head and Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India
    • Corresponding Author InformationCorresponding author. Department of Otolaryngology and Head and Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India. Tel.: +91 0172 2747586 to 94x6759; fax: +91 172 2744401, 2745078.
    • ,
  • Karuppiah Saravanan, DNB, MNAMS

      Affiliations

    • Department of Otolaryngology and Head and Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India
    • ,
  • Arunaloke Chakrabarti, MD, DNB

      Affiliations

    • Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Received 5 October 2006

References 

  1. Stammberger H, Jakse R, Beaufort F. Aspergillosis of the paranasal sinuses: x-ray diagnosis, histopathology and clinical aspects. Ann Otol Rhinol Laryngol. 1984;93:251–256
  2. Hartwick RW, Batsakis JG. Pathology consultation: sinus aspergillosis and allergic fungal sinusitis. Ann Otol Rhinol Laryngol. 1991;100:427–430
  3. Saleh HA, Bridger MW. Invasive aspergillosis of the paranasal sinuses: a medical emergency. J Laryngol Otol. 1997;3:1168–1170
  4. Quiney RE, Rogers MJC, Davidson RN, et al. Craniofacial resection for extensive paranasal sinus aspergilloma. J Laryngol Otol. 1998;102:1172–1175
  5. De Foer C, Fossion E, Vaillant JM. Sinus aspergillosis. J Cranio maxillo fac Surg. 1990;18:33–40
  6. Levin LA, Avery R, Shore JW, et al. The spectrum of orbital aspergillosis: a clinico-pathological review. Surv of ophthalmol. 1996;41:142–154
  7. Mc Gill TJ, Simpson G, Healy GB. Fulminant aspergillosis of the nose and paranasal sinuses: a new clinical entity. Laryngoscope. 1980;90:748–754
  8. Green WR, Font RL, Zimmerman LE. Aspergillosis of the orbit: report of ten cases and review of the literature. Arch Ophthalmol. 1969;82:302–313
  9. Yu VL, Wagner GE, Shadomy S. Sino-orbital aspergillosis treated with combination antifungal therapy: successful therapy after failure with amphotericin B and surgery. JAMA. 1980;244:814–815
  10. Kitahara M, Seth VK, Medoff G. Activity of amphotericin B, 5-flucytosine and rifampin against six clinical isolates of aspergillosis. Antimicrob Agents Chemother. 1976;9:915–919
  11. Harris GJ, Will BR. Orbital aspergillosis: conservative debridement and local amphotericin irrigation. Opthalmic Plast Reconstr Surg. 1989;5:207–211
  12. Adler SC, Isaacson G, Sasaki CT. Invasive aspergillosis of the paranasal sinuses and orbit: can you save the eye?. Am J Otolaryngol. 1997;18:230–234
  13. Dhiwakar M, Thakar A, Bahadur S. Invasive sino-orbital aspergillosis: surgical decisions and dilemmas. J Laryngol Otol. 2003;117:280–285
  14. Mauriello JA, Yepez N, Mostafavi R, et al. Invasive rhinosino-orbital aspergillosis with precipitous visual loss. Can J Ophthalmol. 1995;30:124–130
  15. Massry GG, Homblass A, Harrison W. Itraconazole in the treatment of orbital aspergillosis. Ophthalmology. 1996;103:1467–1470
  16. Sagar AM. Use of amphotericin B with azole anti fungal drugs; what are we doing?. Anti Microb Agents Chemother. 1995;39(9):1907–1912
  17. Popp AI, White MH, Quadri T, et al. Amphotericin B with and without itraconazole for invasive aspergillosis. A three year retrospective study. Int J Infect Dis. 1999;3(3):157–160
  18. Denning DW, Lee JY, Pappas P, Dewsnup DH, Galgiani JN. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med. 1994;97:135–144
  19. Denning DW, Tucker RM, Hanson LH, et al. Treatment of invasive aspergillosis with itraconazole. Am J Med. 1989;86:791–800
  20. Tucker RM, Hanson LH, Denning DW. The interaction of azoles with rifampin, phenytoin and carbamazepine: in vitro and clinical observations. Clin Infect Dis. 1992;14:165–174
  21. Walsh TJ, Finberg RW, Arndt C. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med. 1999;340:764–771
  22. Streppel M, Bachmann G, Damm M, et al. Successful treatment of an invasive aspergillosis of the skull base paranasal sinuses with liposomal amphotericin B and itraconazole. Ann Otol Rhinol Laryngol. 1999;108:205–207
  23. Stevens DA, Kan VL, Judson MA. Practise guidelines for disease caused by aspergillosis. Clin Infect Dis. 2000;30:696–709

☆ This material has never been published and is not currently under evaluation in any other peer-reviewed publication. There is no conflict of interest or financial disclosure to be made.

PII: S0196-0709(06)00312-7

doi: 10.1016/j.amjoto.2006.12.004

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 29, Issue 1 , Pages 24-30 , January 2008

Article Tools

* Image Usage & Resolution